PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Lianqinjiedu decoction attenuates LPS-induced inflammation and acute lung injury in rats via TLR4/NF-kB pathway.

Rat / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28972887 ↗2017Reported benefit

Lianqinjiedu decoction attenuates LPS-induced inflammation and acute lung injury in rats via TLR4/NF-kB pathway.

RatEndotoxin/LPSSprague-Dawleyn = 48 rats randomised into six groups (per-group n not stated)Oral administration0.61, 1.22 and 2.44 g/kg (low, medium and high dose); posit…1 h before intraperitoneal LPS injection (pre-treatment)

Model: Lipopolysaccharide-induced acute lung injury; LPS 0.005 g/kg (E. coli 055:B5) by intraperitoneal injection

LQJD reduced the LPS-induced rise in body temperature, lowered serum TNF-alpha and IL-6, and reduced inflammatory infiltration and alveolar disruption on histology. TLR4 and NF-kBp65 were down-regulated at both mRNA and protein level in lung tissue.

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.